Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Goraya JS et al. - Intravenous levetiracetam recently became available for use in patients aged >16 years. No serious adverse effects were observed, and all patients completed treatment with intravenous levetiracetam for the intended period. Intravenous levetiracetam may be effective in various clinical situations requiring intravenous administration of an antiepileptic drug.

Related Articles

Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09    Relevance Score: 91%

Language lateralization correlates with verbal memory performance in children with focal epilepsy
Epilepsia, 12/07/09    Relevance Score: 89%

The circadian rhythm and its interaction with human epilepsy: A review of literature
Sleep Medicine Reviews, 11/24/09    Relevance Score: 88%

Living with a brother or sister with epilepsy: Siblings’ experiences
Seizure - European Journal of Epilepsy, 11/10/09    Relevance Score: 88%

Psychiatric comorbidity and suicidal behavior in epilepsy: A community-based case–control study
Epilepsia, 11/05/09    Relevance Score: 88%

Today in Neuro/Psych pharmacology...keeping you current

Modafinil for multiple sclerosis fatigue: Does it work
Clinical Neurology and Neurosurgery, 12/18/09

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry in six countries
Current Medical Research and Opinion, 12/18/09

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
Phytotherapy Research, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address